Arteris (NASDAQ:AIP) Given “Buy” Rating at Rosenblatt Securities

Rosenblatt Securities reissued their buy rating on shares of Arteris (NASDAQ:AIP) in a report released on Wednesday morning, Benzinga reports. They currently have a $15.00 target price on the stock.

Separately, Westpark Capital reaffirmed a “buy” rating and issued a $11.00 price target on shares of Arteris in a research note on Wednesday, July 31st.

Arteris Price Performance

AIP opened at $8.50 on Wednesday. The stock has a market cap of $333.71 million, a P/E ratio of -8.59 and a beta of 1.13. Arteris has a 12 month low of $4.20 and a 12 month high of $9.54. The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 0.17. The company has a fifty day simple moving average of $7.33 and a 200 day simple moving average of $7.64.

Insider Transactions at Arteris

In other news, VP Paul L. Alpern sold 3,615 shares of the firm’s stock in a transaction that occurred on Friday, October 4th. The shares were sold at an average price of $7.13, for a total transaction of $25,774.95. Following the completion of the transaction, the vice president now directly owns 68,084 shares of the company’s stock, valued at $485,438.92. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, COO Laurent R. Moll sold 3,801 shares of the firm’s stock in a transaction dated Wednesday, October 2nd. The stock was sold at an average price of $7.18, for a total value of $27,291.18. Following the completion of the transaction, the chief operating officer now owns 490,667 shares in the company, valued at $3,522,989.06. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Paul L. Alpern sold 3,615 shares of the company’s stock in a transaction dated Friday, October 4th. The stock was sold at an average price of $7.13, for a total value of $25,774.95. Following the sale, the vice president now owns 68,084 shares in the company, valued at $485,438.92. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 124,110 shares of company stock valued at $902,044 over the last three months. Company insiders own 33.70% of the company’s stock.

Hedge Funds Weigh In On Arteris

Institutional investors have recently added to or reduced their stakes in the company. US Bancorp DE bought a new position in shares of Arteris in the 3rd quarter valued at about $34,000. The Manufacturers Life Insurance Company acquired a new stake in Arteris in the 2nd quarter valued at about $86,000. Algert Global LLC bought a new position in Arteris during the second quarter worth about $115,000. Rhumbline Advisers increased its position in Arteris by 2,182.8% during the second quarter. Rhumbline Advisers now owns 31,822 shares of the company’s stock worth $239,000 after buying an additional 30,428 shares during the last quarter. Finally, CloudAlpha Capital Management Limited Hong Kong bought a new stake in Arteris in the second quarter valued at approximately $554,000. 64.36% of the stock is currently owned by institutional investors and hedge funds.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.